 |
|
No-Mortality Liver Resection for Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients
Is There a Way? A Prospective Analysis of Our Approach
Guido Torzilli, MD, FPCR;
Masatoshi Makuuchi, MD, PhD;
Kazuto Inoue, MD;
Tadatoshi Takayama, MD, PhD;
Yoshihiro Sakamoto, MD;
Yasuhiko Sugawara, MD;
Keiichi Kubota, MD, PhD;
Alberto Zucchi, MD
Arch Surg. 1999;134:984-992.
Background Low resectability rates and significant morbidity and mortality rates often make surgery for hepatocellular carcinomas (HCCs) unfeasible.
Hypothesis Our policy for surgical treatment of cirrhotic and noncirrhotic patients with HCC is adequate and safe.
Design Prospective validation cohort study.
Setting University hospital.
Patients One hundred seven consecutive patients with HCCs. Associated cirrhosis was present in 64 (59.8%), and only 7 (6.5%) had normal livers.
Interventions The presence of ascites, serum bilirubin level, and indocyanine green retention rate at 15 minutes were considered when selecting patients for surgery. Preoperative recovery of liver function was achieved with portal venous branch embolization, liver volumetry, bed rest, and control of serum aminotransferase levels. The surgical techniques mainly involved bloodless dissection using intraoperative ultrasonography and intermittent warm ischemia. The main perioperative care regimen was fresh frozen plasma infusion and strict limitation of blood transfusion.
Main Outcome Measures The 30-day postoperative mortality and morbidity rates.
Results All the patients underwent surgery (37 major resections, 45 segmentectomies, and 25 limited resections), with no 30-day postoperative mortality, overall morbidity of 26.2%, and no major complications. Multiple logistic regression analysis revealed that only the type of operation was associated with a significantly higher morbidity risk (P=.05).
Conclusion With high resectability, low morbidity, and no mortality, our policy represents a solution to the drawbacks of surgical resection for treatment of HCCs, especially in patients with associated liver cirrhosis.
From the HepatoBiliary Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan (Drs Torzilli, Makuuchi, Inoue, Takayama, Sakamoto, Sugawara, and Kubota); and the Epidemiology Unit, Hospital of Lodi, Lodi, Italy (Dr Zucchi).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Selection for Resection of Hepatocellular Carcinoma and Surgical Strategy: Indications for Resection, Evaluation of Liver Function, Portal Vein Embolization, and Resection
Ribero et al.
Ann. Surg. Oncol. 2008;15:986-992.
FULL TEXT
Kentucky Hepatoma: Epidemiologic Variant or Same Problem in a Different Region?
Martin et al.
Arch Surg 2007;142:431-437.
ABSTRACT
| FULL TEXT
Is Hepatic Resection for Large or Multinodular Hepatocellular Carcinoma Justified? Results From a Multi-Institutional Database
Ng et al.
Ann. Surg. Oncol. 2005;12:364-373.
ABSTRACT
| FULL TEXT
Techniques for Hepatectomies Without Blood Transfusion, Focusing on Interpretation of Postoperative Anemia
Torzilli et al.
Arch Surg 2004;139:1061-1065.
ABSTRACT
| FULL TEXT
Editorial: Improvement of Survival by Surgery in the Treatment of Hepatocellular Carcinoma: Evidence or Non-evidenced-based?
Adam
Ann. Surg. Oncol. 2004;11:460-461.
FULL TEXT
Long-term Results of Hepatic Resection for Hepatocellular Carcinoma Originating From the Noncirrhotic Liver
Chang et al.
Arch Surg 2004;139:320-325.
ABSTRACT
| FULL TEXT
Liver Transplantation and Hepatocellular Carcinoma Biology: Beginning of the End of the Era of Educated Guesses
Vauthey and Ajani
JCO 2003;21:4265-4267.
FULL TEXT
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years
Imamura et al.
Arch Surg 2003;138:1198-1206.
ABSTRACT
| FULL TEXT
Perioperative and Long-term Outcome of Major Hepatic Resection for Small Solitary Hepatocellular Carcinoma in Patients With Cirrhosis
Lang et al.
Arch Surg 2003;138:1207-1213.
ABSTRACT
| FULL TEXT
Long-Term Disease-Free Survival After Resection of Hepatocellular Carcinoma: Both Tumor Behavior and Surgeon's Performance Are Important Determinants
Poon and Wong
Ann. Surg. Oncol. 2003;10:834-836.
FULL TEXT
Outcome of Right Hepatectomies in Patients Older Than 70 Years
Cescon et al.
Arch Surg 2003;138:547-552.
ABSTRACT
| FULL TEXT
Hepatic Resection for Bilobar Hepatocellular Carcinoma: Is It Justified?
Liu et al.
Arch Surg 2003;138:100-104.
ABSTRACT
| FULL TEXT
Effect of Hypoventilation on Bleeding During Hepatic Resection: A Randomized Controlled Trial
Hasegawa et al.
Arch Surg 2002;137:311-315.
ABSTRACT
| FULL TEXT
Randomized Comparison of Ultrasonic vs Clamp Transection of the Liver
Takayama et al.
Arch Surg 2001;136:922-928.
ABSTRACT
| FULL TEXT
A Prospective Longitudinal Study of Quality of Life After Resection of Hepatocellular Carcinoma
Poon et al.
Arch Surg 2001;136:693-699.
ABSTRACT
| FULL TEXT
Receptor Measurements via Tc-GSA Kinetic Modeling Are Proportional to Functional Hepatocellular Mass
Miki et al.
JNM 2001;42:733-737.
ABSTRACT
| FULL TEXT
Underlying Liver Disease, Not Tumor Factors, Predicts Long-term Survival After Resection of Hepatocellular Carcinoma
Bilimoria et al.
Arch Surg 2001;136:528-535.
ABSTRACT
| FULL TEXT
An Appraisal of Liver and Portal Vein Resection for Hepatocellular Carcinoma With Tumor Thrombi Extending to Portal Bifurcation
Wu et al.
Arch Surg 2000;135:1273-1279.
ABSTRACT
| FULL TEXT
Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1
Orii et al.
Br J Anaesth 2000;85:389-395.
ABSTRACT
| FULL TEXT
|
